David Renzi
2014
In 2014, David Renzi earned a total compensation of $527.8K as President and Chief Operating Officer at Carbylan Therapeutics.
Compensation breakdown
| Bonus | $143,522 |
|---|---|
| Salary | $384,271 |
| Total | $527,793 |
Renzi received $384.3K in salary, accounting for 73% of the total pay in 2014.
Renzi also received $143.5K in bonus.
Rankings
In 2014, David Renzi's compensation ranked 10,095th out of 13,032 executives tracked by ExecPay. In other words, Renzi earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,095 out of 13,032 | 23rd |
Division Manufacturing | 3,838 out of 4,965 | 23rd |
Major group Chemicals And Allied Products | 1,319 out of 1,690 | 22nd |
Industry group Drugs | 1,053 out of 1,369 | 23rd |
Industry Pharmaceutical Preparations | 807 out of 1,042 | 23rd |
Source: SEC filing on April 28, 2016.